Pharmaceuticals (78) | Credit Agreements (78)

Browse by Company

Recent Contracts

Fourth Amended and Restated Credit and Security Agreement dated June 4, 2021 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the... (OCULAR THERAPEUTIX, INC, Filed With SEC on June 4, 2021)
Waiver Letter dated May 11, 2011 for Third Amended and Restated Securities Purchase Agreement between the Company, and Gotham Green Admin 1, LLC the Other Credit Parties named... (MedMen Enterprises, Inc., Filed With SEC on May 17, 2021)
Amendment No. 4 to the Credit Agreement, originally dated September 23, 2020, by and between Acreage Finance Delaware, LLC, Acreage IP Holdings, LLC and IP Investment Company, LLP (Acreage Holdings, Inc., Filed With SEC on April 1, 2021)
Third Amending Agreement, effective March 11, 2021, to Credit Agreement originally dated February 7, 2020 (Acreage Holdings, Inc., Filed With SEC on March 26, 2021)
Form of Warrant Agreement for Credit Facilitys Agent and Lenders (Vireo Health International, Inc., Filed With SEC on March 26, 2021)
Credit Agreement, dated March 25, 2021 by and among Vireo Health International, Inc., and certain of its subsidiaries, the persons from time-to-time party thereto as guarantors,... (Vireo Health International, Inc., Filed With SEC on March 26, 2021)
Eight Modification to the Revolving Line of Credit Agreement, dated March 7, 2016, between International Medication Systems, Limited and East West Bank in the principal sum of... (Amphastar Pharma, Filed With SEC on March 15, 2021)
Amendment No. 2 to the Credit Agreement, originally dated March 6, 2020, by and between Acreage Finance Delaware, LLC, Acreage IP Holdings, LLC and IP Investment Company, LLP (Acreage Holdings, Inc., Filed With SEC on March 11, 2021)
Amendment No. 3 to the Credit Agreement, originally dated March 6, 2020, by and between Acreage Finance Delaware, LLC, Acreage IP Holdings, LLC and IP Investment Company, LLP (Acreage Holdings, Inc., Filed With SEC on March 11, 2021)
First Amendment to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as... (OptiNose, Inc., Filed With SEC on March 3, 2021)